A significant advance in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently disabled in many kinds of cancer, https://sound-social.com/story12302979/mini-antibodies-restore-the-p53-protein-new-new-pathway-for-malignant-treatment